| 发明名称 |
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors |
| 摘要 |
The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
|
| 申请公布号 |
US2013171098(A1) |
申请公布日期 |
2013.07.04 |
| 申请号 |
US201313778507 |
申请日期 |
2013.02.27 |
| 申请人 |
BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
BENDER JOHN A.;DING MIN;GENTLES ROBERT G.;HEWAWASAM PIYASENA |
| 分类号 |
A61K31/55;A61K45/06 |
主分类号 |
A61K31/55 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
